Hanmi Pharm Co Ltd
KRX:128940
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hanmi Pharm Co Ltd
KRX:128940
|
KR |
|
Mitra Keluarga Karyasehat Tbk PT
IDX:MIKA
|
ID |
|
Evercore Inc
NYSE:EVR
|
US |
|
V
|
Veeram Securities Ltd
BSE:540252
|
IN |
|
M
|
Maagh Advertising & Marketing Services Ltd
BSE:543624
|
IN |
|
W
|
Wal Mart de Mexico SAB de CV
SWB:4GNB
|
MX |
|
Nippon Soda Co Ltd
TSE:4041
|
JP |
|
Intra Energy Corporation Ltd
ASX:IEC
|
AU |
|
Delta Galil Industries Ltd
OTC:DELTF
|
IL |
|
H
|
Humble Group AB
STO:HUMBLE
|
SE |
|
Hyzon Motors Inc
NASDAQ:HYZN
|
US |
|
I
|
InfuSystem Holdings Inc
AMEX:INFU
|
US |
|
Federal Realty Investment Trust
NYSE:FRT
|
US |
|
A
|
ASM Pacific Technology Ltd
HKEX:522
|
HK |
|
GDS Global Ltd
SGX:5VP
|
SG |
|
Paradox Interactive AB (publ)
OTC:PRXXF
|
SE |
|
H
|
Hangzhou Lion Electronics Co Ltd
SSE:605358
|
CN |
|
Ardent Health Partners Inc
NYSE:ARDT
|
US |
Bankruptcy Probability
Hanmi Pharm Co Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Hanmi Pharm Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
|
Hanmi Pharm Co Ltd
KRX:128940
|
7T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Hanmi Pharm Co Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Hanmi Pharm Co Ltd has total debt of 416.2B KRW. This includes both short-term (319.5B KRW) and long-term (96.7B KRW) debt.
You can find a full breakdown on its Balance Sheet.
